{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreih3uupbj4ezqitnhpdof7zuotohmdkq5dvjq2tsg7pl2mydxlx4ue",
    "uri": "at://did:plc:empjqd66qnuzjesut6yhsux4/app.bsky.feed.post/3moqzqgfbdaa2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiebo6nvp3gnseadqsjcmi56p2e3cxzmjhah77k7hytljjv4zjp4ly"
    },
    "mimeType": "image/webp",
    "size": 20382
  },
  "path": "/wissenschaft/diabetes-wirkstoffe-sglt2-hemmer-senken-alzheimer-risiko-um-43-percent/69593541",
  "publishedAt": "2026-06-20T23:24:19.000Z",
  "site": "https://www.ad-hoc-news.de",
  "textContent": "NIH-Studie belegt: SGLT2-Hemmer und GLP-1-Agonisten verringern Alzheimer-Rate um bis zu 43 Prozent.",
  "title": "Diabetes-Wirkstoffe: SGLT2-Hemmer senken Alzheimer-Risiko um 43%",
  "updatedAt": "2026-06-20T23:24:19.000Z"
}